Presentation is loading. Please wait.

Presentation is loading. Please wait.

Jacques Normand, Ph.D. Director, AIDS Research Program National Institute on Drug Abuse NIDA’s New HIV/AIDS Research Program.

Published byBrandon Chambers Modified over 9 years ago

Similar presentations

Presentation on theme: "Jacques Normand, Ph.D. Director, AIDS Research Program National Institute on Drug Abuse NIDA’s New HIV/AIDS Research Program."— Presentation transcript:

1 Jacques Normand, Ph.D. Director, AIDS Research Program National Institute on Drug Abuse NIDA’s New HIV/AIDS Research Program

2 Objectives Update on NIDA’s New AIDS Research Program –CAMCODA –NIDA Council Recommendations –New AIDS Research Program –Structure –Research Priorities Brief Update on NIDA/NIH Collaborative Projects –Projects and Partners –New HPTN Network Drug Abuse Projects

3 CAMCODA Structure Director Medical Consequence Unit Human Development Unit Population- Based Intervention Unit Deputy Director Staff: 20 Professionals

4 CAMCODA116,035,000 DESPR 57,707,000 DTR&D 54,204,000 DNBR 29,615,000 CTN 12,052,000 NIDA AIDS FY03 AIDS Funding by Divisions

5 NIDA Advisory Council Workgroup on HIV/AIDS Report on Findings and Recommendations February, 2004

6 Structural & Procedural Recommendations Create new position of “Director, AIDS Research Program” reporting to NIDA’s Director Update policy/procedures to determine which projects qualify for AIDS funding Improve articulation of HIV/AIDS mission and planning process within & across Divisions/Centers Increase interaction across NIH, and with extramural community

7 NIDA’s AIDS Research Program Structure AIDS Research Program Mission: Plan, develop, coordinate and integrate research priorities within NIDA and externally. Staff: Jacques Normand Lynda Erinoff Helen Cesari AIDS Workgroup AIDS Coding Subgroup External Scientific AIDS Workgroup TBA

8 Division of Pharmacotherapies and Medical Consequences of Drug Abuse Jag Khalsa Ahmed Elkashef Jamie Biswas Division of Basic Neurosciences and Behavioral Research Diane Lawrence Cora Lee Wetherington Charles Sharp Yu Lin Minda Lynch NIDA’s AIDS Workgroup Membership

9 Division of Epidemiology, Services, and Prevention Research Elizabeth Lambert Division of Clinical Neurosciences, Development and Behavioral Treatment Lisa Onken Melissa Racioppo Nicolette Borek Ro Nemeth Center for Clinical Trials Network Mary Ellen Michel NIDA’s AIDS Workgroup Membership (Cont.)

10 Office of Science Policy & Communication Anna Staton International Program Steve Gust Intramural Research Program John Schmittner Office of Extramural Affairs Mark Green Office of Planning & Research Management Stacy Gardner NIDA’s AIDS Workgroup Membership (Cont.)

11 External Scientific AIDS Workgroup Proposed Membership (~ 8): Council Members Nominee per Division/Center Nominee from AIDS Program Proposed Task: Review NIDA’s AIDS Strategic Plan Review & make recommendations on new AIDS related procedural change (e.g., definition of AIDS and coding guidelines) Review NIDA’s priorities/initiatives

12 DPMC 52,046,000 DESPR 121,656,000 DCNDBT 46,336,000 DBNBR 29,374,000 CCTN 11,557,000 FY04 AIDS Funding by NIDA Divisions

13 NIDA’s FY04 Funding By OAR Research Areas of Emphasis 1.Natural History and Epidemiology $54,246,859 2.Etiology and Pathogenesis $29,028,598 3.Therapeutics $12,084,141 4.Vaccines $1,983,201 5.Behavioral and Social Science $186,583,465 6.Training, Infrastructure, and Capacity Building $6,860,742 7.Information Dissemination $1,594,994

14 Research Priority Recommendations Racial/ethnic disparities Emphasize case finding/treatment HAART interactions/adherence/resistance Newer HIV/IDU epidemics (Russia, China, India, Eastern Europe) Test drug T x for HIV prevention Emerging drugs (e.g., Meth/Viagra, NYC case/immunological & CNS impact ) Sexual risk behaviors (main exposure category) Adolescents (developmental/decision making, impulsivity) Role of drug abuse on transmission (drug type, partnership, context) Update programs with continuous review of epidemiologic and other findings

15 Current NIDA’s AIDS Program Tasks Explore new ways to attract new AIDS PIs Better integrate HIV/AIDS within and across NIDA Divisions/Centers and other NIH Institutes Working on Generating FY07 OAR Priorities (retooling priorities to establish strong presence in all Div/Ctr) Will be Generating NIDA FY06 AIDS Initiatives Developing Criteria for AIDS Grants Will be Appointing Members to Extramural Scientific AIDS Workgroup Will be Developing NIDA’s HIV/AIDS Strategic Plan

16 NIDA’s Collaborative Projects Network/Cohort Collaborating ICsNIDA’s Co-Fund Adolescent Trial Network NICHD, NIMH$1.0/20.0M Pediatric HIV AIDS Cohort Study NICHD, NIAID, NIMH $3.0/12.0M Centers For AIDS Research NIAID, NCI, NHLBI, & NIMH $4.6/33.3M Women Interagency HIV Study NIAID, NICHD, & NCI$0.5/18.5M HIV Prevention Trial Network NIAID,NIMH, NICHD, & FIC $4.4/70.0M

17 HPTN & New NIAID Network Current Projects Epidemiology HIV Prevention Drug Tx as HIV Prevention New Network Proposed protocols Community Scale-up; Stimulant pharmacotherapy as HIV prevention

Download ppt "Jacques Normand, Ph.D. Director, AIDS Research Program National Institute on Drug Abuse NIDA’s New HIV/AIDS Research Program."

Similar presentations

Research Training Programs at the NIH Marya Levintova, Ph.D. International Program Officer for Russia, Eurasia and Arctic Affairs Division of International.

Research Training Programs at the NIH Marya Levintova, Ph.D. International Program Officer for Russia, Eurasia and Arctic Affairs Division of International.
UCSC History. UCSC: A brief history 60s University Placement Committee A lot of field trips/interaction with employers.

UCSC History. UCSC: A brief history 60s University Placement Committee A lot of field trips/interaction with employers.
TM NCI’s Smoking Cessation Activities and Priorities: Discovery, Development and Delivery Scott J. Leischow, Ph.D. National Cancer Institute.

TM NCI’s Smoking Cessation Activities and Priorities: Discovery, Development and Delivery Scott J. Leischow, Ph.D. National Cancer Institute.
Role of the HIV/AIDS community in science & regulatory advocacy Nikos Dedes European AIDS Treatment Group 22 July 2014, Melbourne.

Role of the HIV/AIDS community in science & regulatory advocacy Nikos Dedes European AIDS Treatment Group 22 July 2014, Melbourne.
What’s NIH? National Cancer Institute National Eye Institute National Heart, Lung, and Blood Inst. National Human Genome Research Inst National Institute.

What’s NIH? National Cancer Institute National Eye Institute National Heart, Lung, and Blood Inst. National Human Genome Research Inst National Institute.
NIH Academic Research Enhancement Award (AREA) R15 AASCU November 5, 2009 Mary Ann Guadagno, PhD Office of Extramural Research National Institutes of Health.

NIH Academic Research Enhancement Award (AREA) R15 AASCU November 5, 2009 Mary Ann Guadagno, PhD Office of Extramural Research National Institutes of Health.
Promoting Diversity and Science for Health Equity -- Introduction of NIDA Minority Diversity Programs Yu (Woody) Lin, M.D., Ph.D Program Director Division.

Promoting Diversity and Science for Health Equity -- Introduction of NIDA Minority Diversity Programs Yu (Woody) Lin, M.D., Ph.D Program Director Division.
Institute for Health and Society Institute for Health and Society Improving Health and Advancing Health Equity Through Community and Academic Partnerships.

Institute for Health and Society Institute for Health and Society Improving Health and Advancing Health Equity Through Community and Academic Partnerships.
Public, Private & Faith-based Partnerships in Papua New Guinea How to provide innovative, needs-based programs to support HIV health care capacity building.

Public, Private & Faith-based Partnerships in Papua New Guinea How to provide innovative, needs-based programs to support HIV health care capacity building.
NIH Behavioral and Social Sciences Research: A Snapshot from OBSSR Deborah H. Olster, PhD Deputy Director Office of Behavioral and Social Sciences Research.

NIH Behavioral and Social Sciences Research: A Snapshot from OBSSR Deborah H. Olster, PhD Deputy Director Office of Behavioral and Social Sciences Research.
Introduction to the NIH Grants System

Introduction to the NIH Grants System
Director’s Report to the National Advisory Council on Drug Abuse Director’s Report to the National Advisory Council on Drug Abuse May 22, 2002 (Prepared.

Director’s Report to the National Advisory Council on Drug Abuse Director’s Report to the National Advisory Council on Drug Abuse May 22, 2002 (Prepared.
Division of AIDS, Behavioral and Population Sciences Risk, Prevention and Health Behavior IRG August, 2014 Reorganization/Realignment of RPHB Addictive.

Division of AIDS, Behavioral and Population Sciences Risk, Prevention and Health Behavior IRG August, 2014 Reorganization/Realignment of RPHB Addictive.
J. Nadine Gracia, MD, MSCE Deputy Assistant Secretary for Minority Health (Acting) Office of Minority Health U.S. Department of Health and Human Services.

J. Nadine Gracia, MD, MSCE Deputy Assistant Secretary for Minority Health (Acting) Office of Minority Health U.S. Department of Health and Human Services.
African Americans and HIV: CA Office of AIDS Response Michelle Roland, MD Chief, Office of AIDS California Department of Public Health.

African Americans and HIV: CA Office of AIDS Response Michelle Roland, MD Chief, Office of AIDS California Department of Public Health.
EVOLVING PUBLIC HEALTH AND HEALTH CARE LANDSCAPE AND OPPORTUNITIES FOR CANCER COMMUNICATION NCI Health Communication and Informatics Research Branch CPCRN.

EVOLVING PUBLIC HEALTH AND HEALTH CARE LANDSCAPE AND OPPORTUNITIES FOR CANCER COMMUNICATION NCI Health Communication and Informatics Research Branch CPCRN.
Research Opportunities at the National Institutes of Health

Research Opportunities at the National Institutes of Health
HIV Prevention Trials Network Update Africa Regional Working Group 20 May 2003.

HIV Prevention Trials Network Update Africa Regional Working Group 20 May 2003.
Cedars-Sinai Medical Center Capacity Building in Central and Eastern Europe: Research and Innovation Management Education and Training Innovation 2005.

Cedars-Sinai Medical Center Capacity Building in Central and Eastern Europe: Research and Innovation Management Education and Training Innovation 2005.
Subcommittee on Children on Adolescents Provide input, as appropriate, to NIDA’s increasing programmatic efforts on child and adolescent issues Assist.

Subcommittee on Children on Adolescents Provide input, as appropriate, to NIDA’s increasing programmatic efforts on child and adolescent issues Assist.

Similar presentations

Ads by Google